| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.08 | 0.6 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |